JP2022527917A5 - - Google Patents

Info

Publication number
JP2022527917A5
JP2022527917A5 JP2021557657A JP2021557657A JP2022527917A5 JP 2022527917 A5 JP2022527917 A5 JP 2022527917A5 JP 2021557657 A JP2021557657 A JP 2021557657A JP 2021557657 A JP2021557657 A JP 2021557657A JP 2022527917 A5 JP2022527917 A5 JP 2022527917A5
Authority
JP
Japan
Prior art keywords
cells
aav
sequence
library
heptamer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021557657A
Other languages
English (en)
Japanese (ja)
Other versions
JP7659271B2 (ja
JP2022527917A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/025720 external-priority patent/WO2020198737A1/en
Publication of JP2022527917A publication Critical patent/JP2022527917A/ja
Publication of JP2022527917A5 publication Critical patent/JP2022527917A5/ja
Priority to JP2025044435A priority Critical patent/JP2025098107A/ja
Application granted granted Critical
Publication of JP7659271B2 publication Critical patent/JP7659271B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021557657A 2019-03-28 2020-03-30 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター Active JP7659271B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025044435A JP2025098107A (ja) 2019-03-28 2025-03-19 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962825703P 2019-03-28 2019-03-28
US62/825,703 2019-03-28
PCT/US2020/025720 WO2020198737A1 (en) 2019-03-28 2020-03-30 Engineered adeno-associated (aav) vectors for transgene expression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025044435A Division JP2025098107A (ja) 2019-03-28 2025-03-19 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター

Publications (3)

Publication Number Publication Date
JP2022527917A JP2022527917A (ja) 2022-06-07
JP2022527917A5 true JP2022527917A5 (cg-RX-API-DMAC7.html) 2023-04-06
JP7659271B2 JP7659271B2 (ja) 2025-04-09

Family

ID=72609527

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021557657A Active JP7659271B2 (ja) 2019-03-28 2020-03-30 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター
JP2025044435A Pending JP2025098107A (ja) 2019-03-28 2025-03-19 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025044435A Pending JP2025098107A (ja) 2019-03-28 2025-03-19 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター

Country Status (12)

Country Link
US (1) US20220195458A1 (cg-RX-API-DMAC7.html)
EP (1) EP3947422A4 (cg-RX-API-DMAC7.html)
JP (2) JP7659271B2 (cg-RX-API-DMAC7.html)
KR (2) KR20260036045A (cg-RX-API-DMAC7.html)
CN (1) CN113874387B (cg-RX-API-DMAC7.html)
AU (2) AU2020248116B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021019436A2 (cg-RX-API-DMAC7.html)
CA (1) CA3135292A1 (cg-RX-API-DMAC7.html)
IL (1) IL286725A (cg-RX-API-DMAC7.html)
MX (1) MX2021011701A (cg-RX-API-DMAC7.html)
SG (1) SG11202110165XA (cg-RX-API-DMAC7.html)
WO (1) WO2020198737A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019200016A1 (en) 2018-04-10 2019-10-17 President And Fellows Of Harvard College Aav vectors encoding clarin-1 or gjb2 and uses thereof
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CN111989068B (zh) 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
US11149256B2 (en) 2018-09-26 2021-10-19 California Institute Of Technology Adeno-associated virus compositions for targeted gene therapy
EP3959324B1 (en) 2019-04-26 2025-09-17 President and Fellows of Harvard College Aav vectors encoding mini-pcdh15 and uses thereof
AU2020366531A1 (en) * 2019-10-18 2022-05-26 Research Institute At Nationwide Children's Hospital Gene therapy targeting cochlear cells
FI4103214T3 (fi) 2020-02-13 2026-07-03 Tenaya Therapeutics Inc Geeniterapian vektorit sydänsairauden hoitoon
US12129287B2 (en) 2020-09-14 2024-10-29 President And Fellows Of Harvard College Recombinant adeno associated virus encoding clarin-1 and uses thereof
US20240075167A1 (en) * 2021-02-03 2024-03-07 The Board Of Trustees Of The Leland Stanford Junior University Method of gene delivery to retinal astrocytes
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound
TW202317768A (zh) 2021-07-08 2023-05-01 美商特納亞治療股份有限公司 用於基因療法的優化表現卡匣
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
CN114606264B (zh) * 2022-03-22 2025-08-26 三峡大学 一种用于神经系统药物递送的aav病毒载体
WO2024054864A1 (en) 2022-09-06 2024-03-14 Tenaya Therapeutics, Inc. Cardioprotective heart disease therapies
JP2026509271A (ja) 2023-03-10 2026-03-17 ダイノ セラピューティクス,インコーポレーテッド カプシドポリペプチドおよびその使用方法
EP4695396A1 (en) 2023-04-10 2026-02-18 Tenaya Therapeutics, Inc. Guide rnas, vectors, and virions for targeting mutations in the pln gene
WO2024215655A1 (en) 2023-04-10 2024-10-17 Tenaya Therapeutics, Inc. Cardioprotective bag3 therapies
WO2024220545A2 (en) * 2023-04-17 2024-10-24 The General Hospital Corporation Aav capsids for on-target delivery to spinal cord
EP4698555A1 (en) * 2023-04-18 2026-02-25 uniQure biopharma B.V. Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504490B1 (en) * 1998-10-16 2009-03-17 Oscient Pharmaceuticals Corporation Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
ES2547381T3 (es) * 2004-04-09 2015-10-05 Monsanto Technology, Llc Composiciones y procedimientos de control de infestaciones de insectos en plantas
US7588772B2 (en) * 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
EP2058401A1 (en) * 2007-10-05 2009-05-13 Genethon Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
NZ716102A (en) * 2013-07-22 2021-12-24 The Children’S Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
EP3564379A1 (en) * 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
US10307492B2 (en) * 2014-03-11 2019-06-04 Wayne State University Modified MGLUR6 promoter and methods of use
AU2016366549B2 (en) * 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
GB2545763A (en) * 2015-12-23 2017-06-28 Adverum Biotechnologies Inc Mutant viral capsid libraries and related systems and methods
CA3011939A1 (en) * 2016-02-02 2017-08-10 University Of Massachusetts Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
JP6994018B2 (ja) * 2016-07-26 2022-01-14 バイオマリン ファーマシューティカル インコーポレイテッド 新規アデノ随伴ウイルスキャプシドタンパク質
EP4219806A3 (en) 2017-04-11 2023-09-27 Ruprecht-Karls-Universität Heidelberg Adeno-associated virus library
US11512327B2 (en) * 2017-08-03 2022-11-29 Voyager Therapeutics, Inc. Compositions and methods for delivery of AAV
MX2020001997A (es) * 2017-08-28 2020-07-20 Univ California Variantes de capside de virus adenoasociado y metodos de uso de estas.
CA3092107A1 (en) * 2018-02-28 2019-09-06 The University Of North Carolina At Chapel Hill Methods and compositions for antibody-evading virus vectors
CN109207520B (zh) * 2018-09-25 2022-05-10 北京锦篮基因科技有限公司 Leber遗传性视神经病变的基因药物

Similar Documents

Publication Publication Date Title
CN113874387B (zh) 用于转基因表达的工程化腺相关病毒(aav)载体
CN105408352B (zh) 通过双重aav载体有效递送大基因
JP7182873B2 (ja) 多重ベクターシステム及びその使用
CN112703016B (zh) 肌球蛋白15启动子及其用途
CN100422320C (zh) 编码抗肌萎缩蛋白小基因的dna序列及其使用方法
CN103764831B (zh) 不含衣壳的aav载体、组合物以及制备载体和基因递送的方法
CN114072179B (zh) 肌球蛋白15启动子及其用途
TW202100748A (zh) 恢復肌縮蛋白功能之基於crispr/cas之基因組編輯組合物
JP2021530218A5 (cg-RX-API-DMAC7.html)
US12467066B2 (en) Compositions and methods for treating retinal disorders
CN113785063A (zh) 用于治疗杜氏肌营养不良症的aav载体介导的大规模突变热点缺失
CN108699565A (zh) 用于定向腺相关病毒(aav)的靶向肽
KR20250084964A (ko) 구성적 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
EP4602061A1 (en) Atp7b gene therapy
US20250026795A1 (en) Functional aav capsids for intravitreal administration
KR20230112672A (ko) 신경변성 질환을 위한 유전자 요법
CN121311586A (zh) 耳蜗內毛细胞特异性启动子及其应用
RU2021131423A (ru) Сконструированные аденоассоциированные (aav) векторы для экспрессии трансгена
KR20240052746A (ko) Kcnv2 유전자 요법
WO2025090628A1 (en) Compositions and methods comprising small nuclear rna (snrna) for treating genetic epilepsies
WO2026033140A1 (en) Variant aav capsid polypeptides targeting the eye
WO2025212745A1 (en) Engineered adeno-associated virus (aav) capsid protein and uses thereof
EP4728080A1 (en) A hybrid dual aav vector system with splice enhancer elements for expression of large genes
CN116761812A (zh) Neurod1和dlx2载体